http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-086086-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65586 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2012-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc2cd69930a44dfd5d8143d0dbf6e112 |
| publicationDate | 2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-086086-A1 |
| titleOfInvention | GLUCOSID DERIVATIVES AND USES OF THE SAME |
| abstract | The present further provides a combination of pharmacologically active agents and a pharmaceutical composition. Claim 1: A compound represented by the structural formula (1) or a pharmaceutically acceptable salt thereof, wherein: A is selected from the moieties of the group of formulas ( 2); V is hydrogen, halo or OR1b-; R1, R1a and R1b are independently selected from the group consisting of hydrogen, C1-6 alkyl, C6-10 aryl-C1-4 alkyl, -C (O) -C6-10 aryl and -C (O) -C1-6 alkyl ; R2 and R2a, in each case, are independently selected from the group consisting of halo, hydroxyl, C1-6 alkyl, and C1-6 alkoxy; R 3 is halo, hydroxy, C 1-6 alkyl, C 1-6 haloalkyl, C 3-10 cycloalkyl, C 1-6 alkoxy, or C 1-3 haloalkoxy; R4 is selected from the group of formulas (3); R5 is a side chain of amino acids; R 6 is a C 1-6 alkyl, C 3-10 cycloalkyl, C 3-10 cycloalkyl-C 1-4 alkyl, 3- to 10-membered heterocycloalkyl, (3- to 10-membered heterocycloalkyl) -C 1-4 alkyl, C6 aryl -10, C6-10 aryl-C 1-4 alkyl, 5- to 10-membered heteroaryl, or (5- to 10-membered heteroaryl) -C 1-4 alkyl; R7, for each occurrence, is independently hydrogen, C1-6 alkyl, C3-10 cycloalkyl, C3-10 cycloalkyl-C1-4 alkyl, 3- to 10-membered heterocycloalkyl, (3- to 10-membered heterocycloalkyl) - C1-4 alkyl, C6-10 aryl, C6-10 aryl-C1-4 alkyl, 5- to 10-membered heteroaryl, or (5- to 10-membered heteroaryl) -C 1-4 alkyl; n is 0, 1, 2, or 3, and q is 0, 1 or 2. |
| priorityDate | 2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310 |
Total number of triples: 30.